Headlands Research Further Expands its Leading Clinical Research Site Network by Acquiring Peninsula Research Associates
June 30, 2022 09:00 ET
|
Headlands Research
SAN FRANCISCO, June 30, 2022 (GLOBE NEWSWIRE) -- Headlands Research announced today the acquisition of Peninsula Research Associates (PRA) of Rolling Hills, CA, continuing the growth of its leading...
Groundbreaking Headlands Research and Pfizer Partnership to Significantly Improve Diversity in Clinical Trials
May 19, 2022 09:00 ET
|
Headlands Research
SAN FRANCISCO, May 19, 2022 (GLOBE NEWSWIRE) -- Headlands Research, a leading international network of clinical trial sites, announced today a partnership with Pfizer Inc. to launch new research...
Headlands Research CEO Mark Blumling to Speak at Milken Institute Global Conference
October 14, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that Founder and CEO...
Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease
June 16, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen...
Headlands Research Continues its Rapid Expansion with the Acquisition of Summit Research Network and the Launch of its Fourth Horizons Site
May 13, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced its acquisition of...
Headlands Research Accelerates Growth and Diversity Commitment with the Acquisition of Multi-Site Southern California Based Artemis Institute for Clinical Research
February 17, 2021 09:00 ET
|
Headlands Research
SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired...
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
September 01, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
August 11, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
July 16, 2020 13:28 ET
|
Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program
July 07, 2020 09:00 ET
|
Headlands Research
SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of two large central nervous system...